Healthcare Company Curapel Raises £350K in Venture Capital Funding
Summary
Curapel, a Cardiff, Wales, UK-based healthcare company, raised £350k in equity funding.The company is using the funds to to develop and commercialise its Histimex, Melidex and Olidex products.Founded as a spinout from the University of Manchester by Chief Technology Officer Dr Neil Gibbs and led by Chief Executive Officer Dr Peter Luebcke, Curapel develops innovative new treatments for eczema and psoriasis as well as skin pigmentation conditions.Products include: – Histimex, an oral treatment that has shown early clinical potential in eczema and atopic dermatitis and also has commercial potential as a treatment for paediatric eczema.– Melidex, a cosmetic product designed to even skin tone and treat pigmentation conditions, and – Olidex, a topical treatment for psoriasis.